COCP Insider Trading Activity and SEC Form 4 Filings
COCP insider trading summary
Over the past 12 months, insiders at Cocrystal Pharma, Inc. (COCP) reported 8 open-market purchases worth $227K by 1 insider and no sales on SEC Form 4. Net insider buying was $227K.
Latest COCP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 3, 2026 | Phillip Md Et Al Frost | Director | Buy | $71K (75,000 @ $0.94) |
| Feb 24, 2026 | Phillip Md Et Al Frost | Director | Buy | $20K (20,000 @ $1.00) |
| Feb 6, 2026 | Phillip Md Et Al Frost | Director | Buy | $47K (50,000 @ $0.95) |
| Dec 31, 2025 | Phillip Md Et Al Frost | Director | Buy | $47K (50,000 @ $0.95) |
| Dec 30, 2025 | Phillip Md Et Al Frost | Director | Buy | $19K (20,000 @ $0.97) |
| Nov 26, 2025 | Phillip Md Et Al Frost | Director | Buy | $2K (2,500 @ $0.99) |
| Nov 26, 2025 | Phillip Md Et Al Frost | Director | Buy | $2K (1,500 @ $1.00) |
| Nov 25, 2025 | Phillip Md Et Al Frost | Director | Buy | $19K (20,000 @ $0.94) |
| Apr 4, 2023 | Frost Gamma Investments Trust | 10% Owner | Buy | $2.0M (1,015,229 @ $1.97) |
| Apr 4, 2023 | Phillip Md Et Al Frost | Director | Buy | $2.0M (1,015,229 @ $1.97) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.